CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Matinas BioPharma gets 2027 window to restore NYSE American listing compliance

RegulatoryNeutral
AI Analysis

Summary

Matinas BioPharma has been granted until 2027 to restore compliance with NYSE American listing requirements.

Outcome Details

2027 window granted to restore NYSE American listing compliance

Importance:4/10
Sentiment:
0.20
NYSE Americanlisting complianceregulatorycompliance
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 4, 2026 9:16 PM

Read Original